NEOGEN CHEMICALS LIMITED
NEOGEN · General/Diversified · NSE
₹2,029
Current Market Price
Fair Value (DCF)
₹1,270
Discount to FV
-37.4%
Updated just now
YieldIQ Score
39/100
Piotroski F-Score
2/9
Economic Moat
None
Confidence
18%
ROE
3.5%
Debt/Equity
1.71
WACC
11.1%
Market Cap
₹5,555 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
6.5%
Return on capital employed
EV / EBITDA
43.8×
Enterprise multiple
Debt / EBITDA
10.2×
Leverage vs earnings
Interest Coverage
2.3×
EBIT covers interest
Current Ratio
1.36×
Short-term liquidity
Asset Turnover
0.49×
Revenue per ₹ of assets
Revenue CAGR (3Y)
9.3%
3-year revenue growth
Revenue CAGR (5Y)
20.7%
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹2,028.7
Bear case
Margin of Safety —
Implied upside -162.4%
Base case
Margin of Safety -148.6%
Implied upside -59.8%
Bull case
Margin of Safety -45.4%
Implied upside -31.2%
Ratio Trends
NEOGEN · last 8 annual periods
ROE
3.5%
ROCE
6.5%
Operating Margin
—
Debt / Equity
1.71×
PE
70.5×
EV / EBITDA
34.9×
Historical Financials
NEOGEN · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹475 Cr | ₹660 Cr | ₹671 Cr | ₹778 Cr | ₹862 Cr | +16.1% |
| EBITDA | ₹86.6 Cr | ₹111 Cr | ₹113 Cr | ₹126 Cr | ₹144 Cr | +13.5% |
| EBIT | ₹76.0 Cr | ₹99.9 Cr | ₹94.7 Cr | — | — | +5.7% |
| PAT | ₹44.6 Cr | ₹50.0 Cr | ₹35.6 Cr | ₹34.8 Cr | ₹28.8 Cr | -10.4% |
| EPS (diluted) | ₹18.70 | ₹20.03 | ₹13.96 | — | — | -7.0% |
| CFO | ₹1.4 Cr | ₹-30.4 Cr | ₹-29.1 Cr | ₹196 Cr | ₹-231 Cr | — |
| CapEx | ₹-170 Cr | ₹-104 Cr | ₹-303 Cr | ₹-318 Cr | ₹-556 Cr | — |
| FCF | ₹-169 Cr | ₹-134 Cr | ₹-332 Cr | ₹-122 Cr | ₹-787 Cr | — |
| Total Assets | ₹799 Cr | ₹1054 Cr | ₹1461 Cr | ₹1747 Cr | ₹2902 Cr | +38.0% |
| Total Debt | ₹229 Cr | ₹370 Cr | ₹409 Cr | ₹597 Cr | ₹1395 Cr | +57.1% |
| Shareholders' Equity | ₹439 Cr | ₹483 Cr | ₹760 Cr | ₹789 Cr | ₹816 Cr | +16.8% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
NEOGEN vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
 INDIGOPNTS INDIGO PAINTS LIMITED | -49.3%-33.0% upside | 50 | Above Fair Value | 13.5% | 23.4× |
 LXCHEM LAXMI ORGANIC INDUS LTD | -195.9%-66.2% upside | 15 | Data Limited | 4.0% | 37.8× |
VISHNU VISHNU | — | — | Pending | 13.7% | — |
 RESPONIND RESPONIND | — | — | Pending | 14.8% | — |
POCL POCL | — | — | Pending | 9.8% | — |
Click a ticker to view its fair-value analysis.
Dividend History
7 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹11.00/sh
Last payout
2025-09-19
₹1.00
Peak payout
₹3.00
Trailing yield
0.05%
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
AI Analysis Summary
Model-generated description of metrics. Not investment advice. NEOGEN CHEMICALS LIMITED (NEOGEN.NS) trades at 2028.70 vs a model fair value of 1269.78, a gap of -37.4%. Piotroski F-score: 2/9. Moat la...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of NEOGEN →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for NEOGEN →
Compare
Head-to-head with peers
Compare NEOGEN side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse NEOGENNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.